What is a Z-Pak Best Used For?
A Z-Pak (azithromycin) is best used for treating community-acquired respiratory tract infections caused by atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae), pertussis, and sexually transmitted infections (chlamydia, gonorrhea). 1, 2
FDA-Approved Indications
The FDA label specifies azithromycin is indicated for 2:
Respiratory Infections (Adults)
- Community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in patients appropriate for oral therapy
- Acute bacterial exacerbations of COPD due to H. influenzae, Moraxella catarrhalis, or S. pneumoniae
- Acute bacterial sinusitis due to H. influenzae, M. catarrhalis, or S. pneumoniae
Sexually Transmitted Infections
- Urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeae
- Genital ulcer disease (chancroid) in men due to Haemophilus ducreyi
Other Infections
- Uncomplicated skin and soft tissue infections due to Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiae
- Pharyngitis/tonsillitis caused by S. pyogenes (as alternative to first-line therapy only)
Pediatric Indications 2
- Acute otitis media (ages 6 months and above)
- Community-acquired pneumonia (appropriate for oral therapy)
- Pharyngitis/tonsillitis (ages 2 years and above, as alternative)
Critical Prescribing Considerations
When NOT to Use Azithromycin
Do not use azithromycin for pneumonia in patients with 2:
- Moderate to severe illness requiring hospitalization
- Cystic fibrosis
- Nosocomial infections
- Known or suspected bacteremia
- Elderly or debilitated patients
- Immunodeficiency or functional asplenia
This is crucial because azithromycin achieves low serum concentrations despite high tissue levels, making it inadequate for severe infections or bacteremia 3, 4.
Pertussis: A Key Indication
Azithromycin is the preferred macrolide for pertussis treatment and postexposure prophylaxis 1:
- Infants <6 months: 10 mg/kg/day for 5 days
- Children ≥6 months: 10 mg/kg (max 500 mg) day 1, then 5 mg/kg/day (max 250 mg) days 2-5
- Adults: 500 mg day 1, then 250 mg/day days 2-5
Azithromycin is specifically preferred over erythromycin in infants <1 month because it does not carry the risk of infantile hypertrophic pyloric stenosis (IHPS) 1.
Sexually Transmitted Infections: Evolving Resistance
For chlamydial infections, azithromycin 1 g single dose is FDA-approved 5, 2. However, doxycycline should be preferred when possible because azithromycin efficacy has decreased over time—from 85.3% cure before 2009 to 67.0% since 2009 for Mycoplasma genitalium 6. The WHO 2024 guidelines recommend azithromycin only if doxycycline has failed, is contraindicated, or if adherence is a major concern 6.
For gonorrhea, azithromycin should NOT be used as monotherapy due to resistance 7. It may be used in combination regimens for treatment failures, but this requires specialist consultation.
Community-Acquired Pneumonia: Specific Context
For hospitalized CAP patients without severe illness, azithromycin can be used either 8:
- As monotherapy (500 mg IV daily for 2-5 days, then 500 mg PO daily for total 7-10 days) in patients without cardiopulmonary disease or DRSP risk factors
- In combination with a β-lactam for broader coverage
For severe CAP requiring ICU admission, azithromycin should be combined with a β-lactam active against drug-resistant S. pneumoniae 8. Monotherapy is not recommended for severe disease.
The European guidelines support azithromycin for community-acquired lower respiratory tract infections, with dosing of 500 mg daily for 3 days or 500 mg day 1 then 250 mg daily for 5 days 9.
Important Caveats
Resistance Concerns
- Pneumococcal resistance: Azithromycin should be avoided as first-line for pneumococcal infections when resistance rates are high 10
- Streptococcal pharyngitis: Penicillin remains the drug of choice; azithromycin is only for penicillin-allergic patients 2
- Susceptibility testing should be performed when treating S. pyogenes infections 2
Cardiac Safety
Azithromycin can prolong QTc interval, risking torsades de pointes 11, 12. Obtain baseline ECG in patients with cardiac risk factors before prescribing.
Not Effective For
- Syphilis: Cannot be relied upon to treat syphilis 2
- COVID-19: Multiple RCTs show no mortality benefit 13, 14
- Severe infections with bacteremia risk: Low serum levels make it inadequate 10, 3
Practical Dosing Summary
Standard adult regimen 2:
- 500 mg day 1, then 250 mg daily days 2-5 (total 1.5 g over 5 days)
Alternative regimens exist for specific infections—refer to FDA label for details 2.
The key advantage of azithromycin is its convenient once-daily dosing and short course, improving compliance 15, 3. However, this convenience must be balanced against appropriate indication selection and growing resistance patterns.